Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Adherence to local and international safety protocols, including SDS handling and PPE
Even if the FDA adopts the recommendation, BPC-157 would remain prescription-only, available through a licensed pharmacy and requiring a clinician to weigh a patients history against still-limited evidence
This gives AHK-Cu a more direct connection to follicle-focused laboratory research
GENERAL CONSIDERATIONS Medical Consultation: Always consult with a healthcare provider or medical professional before starting any peptide-based treatment
B12 shots, NAD IV therapy, and MIC injections Miami providers address nutrient levels, hydration, and cellular energy, without changing how hungry someone feels or how food is absorbed
Phase 1: Weeks 13 (Disc Repair Priority) BPC-157: 500mcg/day subQ TB-500: 2.5mg/week subQ GHK-Cu: 1mg/day subQ Focus: disc tissue repair, nerve decompression, anti-inflammation Activity: physical therapy, gentle mobility, no loading Phase 2: Weeks 48 (Add Recomp Layer) Continue Phase 1 stack Add CJC-1295 no DAC + Ipamorelin: 100mcg each, pre-bed This layer drives GH pulsatility for tissue remodeling and begins the body recomposition phase Activity: begin light lifting as cleared by PT Phase 3: Weeks 9+ (Maintenance and Fat Loss) TB-500: Drop to maintenance 1.25mg/week BPC-157: Can drop to 250mcg/day or 5 days/week CJC+Ipa: Continue pre-bed Optional add: Tesamorelin (12mg/day, 5 days/week) for visceral fat and GH optimization pairs well with CJC+Ipa Optional add: Retatrutide for more aggressive fat loss if that's a priority What to Expect: Recovery Timeline Weeks 12: Reduced acute nerve pain is often the first noticeable change
US$ 25.46
US$ 20.02
US$ 28.09
US$ 24.52
US$ 22.56
US$ 23.40
US$ 20.99
US$ 21.97
US$ 25.59
US$ 27.78
US$ 26.81
US$ 20.97
